25.03.2013
- Delays in developing copies of Roche's top-selling biotech drug are justifying the Swiss company's decision to stay out of biotech generics to focus on improved, patented versions...
25.09.2012
- Pharmaceuticals - Of the many challenges inherent with biosimilar development, the inability to predict market expectations may top the list for decision makers. While uncertainty...
